TRIM33 and non-small cell lung carcinoma: Combined with the aforementioned results obtained in Figs. 2, 3, and Additional file 5: Figure S3, these findings confirmed that circPTK2 protected TIF1γ by sponging out miR-429/miR-200b-3p in NSCLC cells.